S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Closed â€ĸ 04:29 PM ET

DXR

Daxor Corporation

Price Chart
Latest Quote

$9.75

+0.35 (+3.70%)
Current Price
Previous Close $9.40
Open $9.39
Day High $9.75
Day Low $9.37
Volume 3,363
Fetched: 2026-06-21T04:11:03
Stock Information
Shares Outstanding 5.84M
Revenue $27K
Net Income $9.17M
Sector Healthcare
Industry Medical Instruments & Supplies
Market Cap $56.92M
P/E Ratio 5.95
EPS (TTM) $1.64
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Sales$27K
Income$9.17M
Book/sh$9.07
Financial Ratios
Current Ratio0.08
EPS Growth TTM340.20%
Returns & Margins
ROA-1.64%
ROE22.45%
Gross Margin100.00%
Operating Margin-9660.55%
Profit Margin34359.16%
Ownership
Insider Ownership48.94%
Institutional Ownership6.99%
Insider & Institutional transactions data not available
Valuation Ratios
P/S2132.89
P/B1.08
Analyst Data
Recommendationnone
Target Price$22.50
Technical Indicators
SMA20$10.15
SMA50$10.22
SMA200$11.87
RSI44.44
ATR0.6400
Shares Float2.57M
Short Float0.21%
Short Ratio0.74
Volatility0.26
Rel Volume1.60
Performance History
Week-0.10%
Month-14.17%
Quarter-12.32%
6 Months-20.80%
YTD-32.10%
Year+8.33%
3 Years+1.04%
5 Years-22.25%
10 Years+26.98%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $9.75 3,600
2026-06-17 $9.40 500
2026-06-16 $10.00 1,900
2026-06-15 $9.67 1,400
2026-06-12 $9.26 1,300
2026-06-11 $9.76 0
2026-06-10 $9.76 3,800
2026-06-09 $10.00 7,300
2026-06-08 $10.10 4,800
2026-06-05 $10.60 500
2026-06-04 $11.09 1,000
2026-06-03 $10.73 500
2026-06-02 $10.36 1,400
2026-06-01 $10.06 900
2026-05-29 $10.28 1,700
2026-05-28 $9.88 3,200
2026-05-27 $10.17 1,000
2026-05-26 $10.56 7,400
2026-05-22 $10.82 0
2026-05-21 $10.82 2,800
2026-05-20 $11.35 1,400
2026-05-19 $11.36 3,200
About Daxor Corporation

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

📰 Latest News
Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha
MarketBeat â€ĸ 2026-03-15T15:15:25Z
Article thumbnail
Period:
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $10,303,455 $2,130,893 $1,280,515 $6,310,294
Operating Revenue $10,303,455 $2,130,893 $1,280,515 $6,310,294
Expenses
Interest Expense $15,963 $85,089 $49,102 $72,454
Operating Expense $1,133,681 $1,594,559 $999,875 $1,132,161
Other Operating Expenses $40,640 $54,791 $60,812 $46,675
General And Administrative Expense $327,135 $294,185 $307,362 $1,085,486
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $9,169,774 $536,334 $280,640 $5,178,133
Net Interest Income $-15,963 $-85,089 $-49,102 $-72,454
Interest Income $0 $0 $0 $0
Normalized Income $9,169,774 $536,334 $280,640 $5,178,133
Net Income From Continuing And Discontinued Operation $9,169,774 $536,334 $280,640 $5,178,133
Net Income Common Stockholders $9,169,774 $536,334 $280,640 $5,178,133
Net Income $9,169,774 $536,334 $280,640 $5,178,133
Net Income Including Noncontrolling Interests $9,169,774 $536,334 $280,640 $5,178,133
Net Income Continuous Operations $9,169,774 $536,334 $280,640 $5,178,133
Pretax Income $9,169,774 $536,334 $280,640 $5,178,133
Per Share
Diluted EPS $1.64 $-0.09 $0.14 $0.87
Basic EPS $1.64 $-0.09 $0.14 $0.87
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Diluted Average Shares $4,985,286 $4,842,476 $4,631,255 $4,083,847
Basic Average Shares $4,985,286 $4,842,476 $4,631,255 $4,083,847
Diluted NI Availto Com Stockholders $9,169,774 $536,334 $280,640 $5,178,133
Tax Provision $0 $0 $0 $0
Gain On Sale Of Security $476,736 $-255,382 $34,426,839 $-584,998
Selling General And Administration $327,135 $294,185 $307,362 $1,085,486
Fetched: 2026-06-21
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $45,887,266 $35,792,301 $34,010,384 $28,969,469
Total Assets $46,009,861 $36,632,597 $34,869,142 $30,261,069
Investmentin Financial Assets $46,000,000 $36,614,029 $34,843,260 $30,223,230
Financial Assets Designatedas Fair Value Through Profitor Loss Total $46,000,000 $36,614,029 $34,843,260 $30,223,230
Receivables - $9,678 $14,198 $17,233
Prepaid Assets - - - $20,606
Cash Cash Equivalents And Federal Funds Sold - - - -
Debt
Net Debt - $729,966 $755,659 $1,229,164
Total Debt - $729,966 $755,659 $1,229,164
Long Term Debt And Capital Lease Obligation - $729,966 $755,659 $1,229,164
Liabilities
Total Liabilities Net Minority Interest $122,595 $840,296 $858,758 $1,291,600
Payables $122,595 $110,330 $103,099 $62,436
Total Tax Payable $10,595 - - -
Accounts Payable $112,000 - - -
Derivative Product Liabilities - - - -
Equity
Common Stock Equity $45,887,266 $35,792,301 $34,010,384 $28,969,469
Total Equity Gross Minority Interest $45,887,266 $35,792,301 $34,010,384 $28,969,469
Stockholders Equity $45,887,266 $35,792,301 $34,010,384 $28,969,469
Retained Earnings $34,799,231 $25,629,456 $25,093,122 $24,786,362
Other
Treasury Shares Number $475,000 $475,000 $510,183 $1,025,466
Ordinary Shares Number $5,059,640 $4,934,182 $4,806,347 $4,291,064
Share Issued $5,534,640 $5,409,182 $5,316,530 $5,316,530
Tangible Book Value $45,887,266 $35,792,301 $34,010,384 $28,969,469
Treasury Stock $4,496,943 $4,496,943 $4,826,943 $8,771,026
Additional Paid In Capital $15,529,632 $14,605,696 $13,691,039 $12,900,967
Capital Stock $55,346 $54,092 $53,166 $53,166
Common Stock $55,346 $54,092 $53,166 $53,166
Investments And Advances $46,000,000 $36,614,029 $34,843,260 $30,223,230
Invested Capital - $36,522,267 $34,766,043 $30,198,633
Total Capitalization - $36,522,267 $34,766,043 $30,198,633
Fetched: 2026-06-21
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $570,936 $25,692 $-3,655,068 $-769,298
Operating Activities
Operating Cash Flow $570,936 $25,692 $-3,655,068 $-769,298
Financing Activities
Financing Cash Flow $-570,936 $-25,692 $3,655,068 $58,598
Net Other Financing Charges $159,285 $0 $0 $0
Issuance Of Capital Stock - - $4,529,840 $1,851,975
Net Common Stock Issuance - - $4,529,840 $1,851,975
Common Stock Issuance - - $4,529,840 $1,851,975
Other
Repayment Of Debt $-1,422,054 $-2,051,626 $-4,586,407 $-5,871,712
Issuance Of Debt $691,833 $2,025,934 $4,112,901 $4,078,335
End Cash Position $0 $0 $0 $0
Beginning Cash Position $0 $0 $0 $710,700
Changes In Cash $0 $0 $0 $-710,700
Net Issuance Payments Of Debt $-730,221 $-25,692 $-473,506 $-1,793,377
Net Long Term Debt Issuance $-730,221 $-25,692 $-473,506 $-1,793,377
Long Term Debt Payments $-1,422,054 $-2,051,626 $-4,586,407 $-5,871,712
Long Term Debt Issuance $691,833 $2,025,934 $4,112,901 $4,078,335
Change In Working Capital $21,228 $14,092 $52,622 $-9,005
Change In Other Current Liabilities $0 $0 $0 $-22,472
Change In Accrued Expense $17,500 $-8,599 $40,664 $-22,472
Change In Payable $0 $0 $0 $0
Change In Prepaid Assets $-5,970 $18,171 $8,923 -
Change In Receivables $9,698 $4,520 $3,035 $13,467
Other Non Cash Items $1,034,504 $2,860,128 $33,007,146 $-8,713,358
Gain Loss On Investment Securities $-9,654,570 $-3,384,862 $-36,995,476 $2,774,932
Net Income From Continuing Operations $9,169,774 $536,334 $280,640 $5,178,133
Fetched: 2026-06-21